Pages that link to "Template:DocumentData"
From GxPlex
The following pages link to Template:DocumentData:
Displaying 50 items.
- Document:ICH ICH Guidelines - (transclusion) (← links)
- Document:IMDRF IMDRF – Guidelines - (transclusion) (← links)
- Document:INT ISPE - GPP Revision 3 (2015) (transclusion) (← links)
- Document:INT Nuremberg Code 1947 (transclusion) (← links)
- Document:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 (transclusion) (← links)
- Document:N.A. (STROBE)statement: guidelines for reporting observational studies Apr-2008 (transclusion) (← links)
- Document:N.A. Article from Mora et al. 2023 (transclusion) (← links)
- Document:N.A. SPIRIT 2013 - Chan et al. 2013 (transclusion) (← links)
- Document:WHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report (transclusion) (← links)
- Document:WHO WHO - Guidance for best practices for clinical trials 2024 (transclusion) (← links)
- Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 (transclusion) (← links)
- Document:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 (transclusion) (← links)
- Document:WHO WHO - ICD 11 (transclusion) (← links)
- Document:WHO World Health Organization - (transclusion) (← links)
- Document:WMA Declaration of Helsinki 2024 (transclusion) (← links)
- Document:DEU Deutsches Ärzteblatt 45849 (transclusion) (← links)
- Document:EU European Medicines Agency’s Data Protection: Notice For Microsoft (MS) Copilot 365 - EMA pilot phase ; EMA/216030/2025 45838 (transclusion) (← links)
- Document:WHO WHO Good Practices for Clinical Trial Design and Implementation 04-May-2026 (transclusion) (← links)
- Document:N.A. Minimum Criteria for ICH E6 (R3) GCP Investigator Site Personnel Training V3.0 (transclusion) (← links)
- Document:N.A. Transcelerate GCP mutual recognition programm FAQ 21-May-2025 (transclusion) (← links)
- Document:GBR MHRA GCP Inspection Dossier template V7.0 (transclusion) (← links)
- Document:USA WARNING LETTER - Purolea Cosmetics Lab MARCS-CMS 722591 46114 (transclusion) (← links)
- Document:DEU Richtlinie zur Bewertung der Qualifikation von Prüfern, Hauptprüfern, Leitern und ärztlichen Mitgliedern von Prüfungsteams durch Ethik-Kommissionen von Arbeitskreis Medizinischer Ethik-Kommissionen in der Bundesrepublik Deutschland e. V. und (transclusion) (← links)
- Reference:ICH ICH E6 Guideline R3 (2025) Appendix B. B4 (transclusion) (← links)
- Reference:WHO WHO - Guidance for best practices for clinical trials 2024 1.1 - Clinical Research (transclusion) (← links)
- Reference:WHO WHO - Guidance for best practices for clinical trials 2024 1.4 (transclusion) (← links)
- Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 6.3 (transclusion) (← links)
- Reference:INT Nuremberg Code 1947 Code (transclusion) (← links)
- Reference:WMA Declaration of Helsinki 2024 - (transclusion) (← links)
- Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - Good Clinical Practice (GCP) (transclusion) (← links)
- Reference:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 WHO Principles of GCP (transclusion) (← links)
- Reference:EUR European Bioethics Convention 1997 - (transclusion) (← links)
- Reference:ICH ICH E6 Guideline R3 (2025) I (transclusion) (← links)
- Reference:ICH ICH E6 Guideline R3 (2025) II (transclusion) (← links)
- Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Clinical Trial (transclusion) (← links)
- Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - clinical trial (transclusion) (← links)
- Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 3.8 (transclusion) (← links)
- Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - pharmaceutical product (transclusion) (← links)
- Reference:WHO WHO - Guidance for best practices for clinical trials 2024 1.1 - NIS (transclusion) (← links)
- Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex I 6.3 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 1 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 2 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 3 (transclusion) (← links)
- Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 4 (transclusion) (← links)
- Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 4 – 8 (transclusion) (← links)
- Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 10 – 12 (transclusion) (← links)
- Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 14 (transclusion) (← links)
- Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 46 (transclusion) (← links)
- Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 52 (transclusion) (← links)
- Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 2 Paragraph 45 (transclusion) (← links)